Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -1.64% vs 16.79% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 153.53% vs -46.57% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 93.25% vs -35.13% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs 29.41% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Mayinglong Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -1.64% vs 16.79% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.36% vs 1.64% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 153.53% vs -46.57% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 4.43% vs 3.35% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 93.25% vs -35.13% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -4.42% vs 3.11% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs 29.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -15.38% vs -31.58% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






